Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Masuda

Showing results (211-220 of 277) with videos related to

Pageof 28
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1990
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy]N Takifuji, M Fukuoka, S Negoro, et al.
Breast Cancer Research and Treatment|June 24, 2011
Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution surveyK Kawaguchi, H Ishiguro, S Morita, et al.
Radiology|July 29, 1998
Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapyT Tada, K Minakuchi, M Koda, et al.
Biochemical and Biophysical Research Communications|January 7, 2000
Identification of a novel human voltage-gated sodium channel alpha subunit gene, SCN12AS Y Jeong, J Goto, H Hashida, et al.
Internal Medicine (Tokyo, Japan)|August 1, 1992
Coronary artery disease in patients with arteriosclerosis obliterans of the lower extremities or aortic aneurysmS Aoshima, H R Bang, N Masuda, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Phase I/II pharmacokinetic and pharmacogenomic study of UGT1A1 polymorphism in elderly patients with advanced non-small cell lung cancer treated with irinotecanN Yamamoto, T Takahashi, H Kunikane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2009
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)N Katsumata, T Watanabe, H Minami, et al.
Cancer Letters|April 27, 2001
Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancersH Kato, M Yoshikawa, T Miyazaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2010
Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1)S Ohno, Y Rai, H Iwata, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 6, 2004
Interferon-gamma and granulocyte colony-stimulating factor in bronchoalveolar lavage fluid after oesophagectomyK Tsukada, T Miyazaki, H Katoh, et al.
Pageof 28

Showing results (211-220 of 277) with videos related to

Sort By:
Pageof 28
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1990
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy]N Takifuji, M Fukuoka, S Negoro, et al.
Breast Cancer Research and Treatment|June 24, 2011
Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution surveyK Kawaguchi, H Ishiguro, S Morita, et al.
Radiology|July 29, 1998
Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapyT Tada, K Minakuchi, M Koda, et al.
Biochemical and Biophysical Research Communications|January 7, 2000
Identification of a novel human voltage-gated sodium channel alpha subunit gene, SCN12AS Y Jeong, J Goto, H Hashida, et al.
Internal Medicine (Tokyo, Japan)|August 1, 1992
Coronary artery disease in patients with arteriosclerosis obliterans of the lower extremities or aortic aneurysmS Aoshima, H R Bang, N Masuda, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Phase I/II pharmacokinetic and pharmacogenomic study of UGT1A1 polymorphism in elderly patients with advanced non-small cell lung cancer treated with irinotecanN Yamamoto, T Takahashi, H Kunikane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2009
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)N Katsumata, T Watanabe, H Minami, et al.
Cancer Letters|April 27, 2001
Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancersH Kato, M Yoshikawa, T Miyazaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2010
Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1)S Ohno, Y Rai, H Iwata, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 6, 2004
Interferon-gamma and granulocyte colony-stimulating factor in bronchoalveolar lavage fluid after oesophagectomyK Tsukada, T Miyazaki, H Katoh, et al.
Pageof 28